Preventative and treatment effects of morinda citrifolia on diabetes and its related conditions

A method for treating and preventing diabetes comprising the steps of:

• obtaining a naturaceutical formulation comprising a processed Morinda citrifolia product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight;
• and
• orally administering a safe, pre-determined amount of said naturaceutical formulation for safe, pre-determined frequency for a safe, pre-determined duration.

30-53. (canceled)

A method for balancing insulin output and glucose transfer, said method comprising the steps of:

• introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed Morinda citrifolia products, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight;
• and
• administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.

A method for reducing the onset potential of diabetes, said method comprising the steps of:

• introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed Morinda citrifolia product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight;
• and
• administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.

A method for reducing glucose synthesis in the liver, said method comprising the steps of:

• introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed Morinda citrifolia product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight;
• and
• administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.

A method for accelerating glucose metabolism in the body of a mammal, said method comprising the steps of:

• introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed Morinda citrifolia product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight;
• and
• administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.

A method for inhibiting glucose absorption in the digestive tract of a mammal, said method comprising the steps of:

• introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed Morinda citrifolia product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight;
• and
• administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.

A method for improving glucose tolerance in the body of a mammal, said method comprising the steps of:

• introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed Morinda citrifolia product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight;
• and
• administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.

A method for inhibiting the drug breakdown functions of cytochrome enzymes for the purpose of treating diabetes comprising the steps of:

• administering a diabetes medication to a patient;
• administering a naturaceutical to said patient concurrently with said diabetes medication, said naturaceutical comprising a processed Morinda citrifolia product, guercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight, that reduces and inhibits the breaking down or metabolizing of said diabetes medication by inhibiting the medication breakdown functions of said cytochrome enzymes, thus increasing the efficacy of said diabetes medication.